The prevalence of end-stage renal disease is rising across the globe, with diabetes
as the leading cause in half of those affected [
[1]
]. As a result of global industrialization with the popularity of unhealthy diets and
physical inactivity, obesity and diabetes are epidemics affecting many individuals
worldwide including the youth populations. The decline in the age of onset of diabetes
and the increased risk of cardio-renal complications in young-onset diabetes are especially
worrisome [
[2]
]. Furthermore, the impact of the recent coronavirus disease 2019 (COVID-19) pandemic
and its related influence on the change of lifestyle habits and the consequences on
physical and mental health remain to be seen in the long run [
[3]
].To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Primary Care DiabetesAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Reported Cases of End-Stage Kidney Disease - United States, 2000-2019.MMWR Morb. Mortal. Wkly Rep. 2022; 71: 412-415https://doi.org/10.15585/mmwr.mm7111a3
- Prospective study on the incidences of cardiovascular-renal complications in chinese patients with young-onset type 1 and type 2 diabetes.Diabetes Care. 2014; 37: 149-157
- Influence of COVID-19 pandemic and related quarantine procedures on metabolic risk. Prim Care.Diabetes. 2021; 15: 745-750https://doi.org/10.1016/j.pcd.2021.07.008
- Kidney health for everyone everywhere - from prevention to detection and equitable access to care.Kidney Int. 2020; 97: 226-232
- Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes 2022.Diabetes Care. 2022; 45: S125-S143https://doi.org/10.2337/dc22-S009
- Executive summary of the KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease: an update based on rapidly emerging new evidence.Kidney Int. 2022; 102: 990-999https://doi.org/10.1016/j.kint.2022.06.013
- Prescriber uncertainty as opportunity to improve care of type 2 diabetes with chronic kidney disease: mixed methods study.J. Gen. Intern Med. 2022; https://doi.org/10.1007/s11606-022-07838-1
- Self-rated knowledge and competence regarding the management of chronic kidney disease in primary care: a cross-sectional European survey of primary care professionals.Prim. Care Diabetes. 2023;
Article info
Publication history
Published online: January 17, 2023
Identification
Copyright
© 2023 Primary Care Diabetes Europe. Published by Elsevier Ltd. All rights reserved.
